Arcutis Biotherapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.

Real-time index price for Nasdaq Global Market Composite Index (NQGM), along with buy or sell indicators, analysis, charts, ...

Charles Schwab's net interest income advantage, disciplined cost management, and core asset growth drive strong EPS growth.